To learn more about the design of our clinical programs and participating investigators, go to https://clinicaltrials.gov/.
The PROTECT Study (Prospective Observational Trial to Evaluate the Correlation of T-SPOT® Response to CMV Infection and T cell-mediated Acute Graft Rejection)
A Non-interventional Observational Study to Evaluate T-cell Responses in Kidney Transplantation Recipients
Protocol Number: US OH 124
The REACT Study
(A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events – Assessed by a CMV–specific T-SPOT Assay)
A Non-interventional Observational Study to Evaluate T-cell Responses in Hematopoietic Stem Cell and Tadalafil Transplantation Recipients :
Protocol Number: US OI 125.